International Nonproprietary Names

Raffaele Colombo: Njardarson’s Group’s Top 200 Brand Drugs by Sales

Raffaele Colombo, Associate Director, Medicinal Chemistry at Zymeworks, posted on X:

“Every year, the Njardarson’s group (University of Arizona) compiles the top 200 brand drugs by sales. The 2024 list is now posted!
For ADCs, 2023 vs 2024 ranks:
Enhertu 65 to 51
Padcev >200 to 73
Kadcyla 67 to 94
Trodelvy 162 to146
Polivy 169 to 159
Total ~$13 billions!”

Raffaele Colombo: Njardarson's Group's Top 200 Brand Drugs by Sales

More posts featuring Raffaele Colombo.

cancer Njardarson OncoDaily Oncology Raffaele Colombo University of Arizona